Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…: p=0,0482; Anti-IL12/23 vs Anti-TNF: p=0,0480; Risankizumab vs Ustekinumab: p=0,0116. No significant differences were found between Risank…
…patient palliative care intervention arms and by disease group (cancer and end stage organ failure) over 12 monthsSubgroup analyses Su…
…anion diagnostic for pembrolizumab in advanced solid tumors. In MSS mCRC, TMB from tumor tissue (tTMB) provided no predictive utility to…
…nd 13 days from starting treatment to discharge. For diagnosis, Xpert-Ultra MTB-RIF was used in 61 patients (91%) and 54 (81%) tested positive. Med…
…afibranor initiation. 2 (7.4%) patients continued OCA alongside elafibranor. 19 (70.4%) patients had trialled bezafibrate prior to elafibra…
…as performed to reduce treatment selection bias using age, sex, Eastern Cooperative Oncology Group performance status, metastatic burden, primary tumour location and baseline albumi…
…rvice (NIFRS) 334 (2.3%) calls. Both attended 274 (1.9%) calls. CPR: Of the calls with PSNI/NIFRS on scene (n=7,124), 757 (10.6%) r…
…ith decreased risk of psychiatric hospitalisations while add-on atomoxetine was not. Findings on substance-use-related hospitalisations wer…
…114 male and 50 female (unspecified 17). The ICIs involved were nivolumab (n=68), pembrolizumab (n=51), ipilimumab (n=35), atezolizumab (…
…easures are needed to enable personalised pathophysiology-based asthma management.…
…atistically significant p = 0.0114 (<0.05)Conclusion Historical asthma diagnoses are common in bronchiectasis patients, but updated gu…
… been approved for human use: FLyP, LyoPlas, Bioplasma FDP, and OctaplasLG Powder. All of these are freeze-dried in glass bottles and produced by…